News
By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' ...
Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay ...
Police arrested an Oberlin boy, 17, after he punched, slapped and choked his live-in girlfriend in a moving car.
59m
InvestorsHub on MSNGilead shares drop after CVS delays coverage for HIV prevention shot
Gilead Sciences (NASDAQ:GILD) saw its stock decline 2.7% in pre-market trading Thursday following news that CVS Health ...
A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's proven effectiveness ...
A Brooklyn man was arrested weeks after allegedly stealing hundreds of dollars worth of protein shakes from a CVS in ...
3h
TCPalm on MSNIs August too soon for a flu shot? Here’s when, where to get this year’s flu vaccine
Is August too early to get this year’s influenza vaccine? Here’s when and where flu shots are available and when the CDC recommends getting one.
Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...
"Two children are gone, two families are shattered, and it never should have happened,” said Marion County Prosecutor Ryan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results